<DOC>
	<DOCNO>NCT00963976</DOCNO>
	<brief_summary>Rationale : Management blood pressure ( BP ) acute phase intracerebral hemorrhage ( ICH ) remain controversial . Although establish transient moderate reduction perihematoma cerebral blood flow ( CBF ) acute ICH , effect BP treatment unknown . The potential exacerbation CBF preclude routine aggressive BP reduction . Aim Hypothesis : The primary study aim demonstrate feasibility safety acute BP reduction &lt; 150 mmHg systolic use standardize protocol ICH patient . It hypothesize CTP demonstrate evidence perihematoma ischemia follow acute BP reduction . Design : ICH ADAPT randomize blind endpoint trial . Acutely hypertensive ICH patient randomize target systolic BP &lt; 150 mmHg &lt; 180 mmHg . Patients treat intravenous ( IV ) labetalol/hydralazine/enalapril . Study Outcomes : The primary outcome cerebral blood flow perihematoma region , measure CT perfusion , 2 hour randomization . Secondary outcome include difference BP 1 2 hour post-randomization two treatment group hematoma expansion rate 24 hour . Discussion : ICH ADAPT randomize trial design specifically identify hemodynamic change perihematoma region secondary aggressive BP management . The result trial facilitate ongoing future study aim determine efficacy rapid BP reduction acute ICH .</brief_summary>
	<brief_title>Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<criteria>Age ≥18 year Acute primary ICH demonstrate CT scan Onset ≤ 24 h prior randomization Contraindication BP reduction i.e. , severe arterial stenosis highgrade stenotic valvular heart disease Indication urgent BP reduction i.e. , hypertensive encephalopathy , aortic dissection Definite evidence ICH secondary underlying cerebral vascular pathology , i.e. , AVM , aneurysm , tumour , trauma , vasculitis , hemorrhagic transformation ischemic infarct Previous ischemic stroke within 30 day current event NB : Prior ICH exclusion criterion Planned surgical resection hematoma NB : Extraventricular Drain placement exclusion criterion Contraindication CT perfusion imaging ( i.e . contrast allergy , metformin use Creatinine &gt; 160 μmol/l )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Cerebral Blood Flow</keyword>
	<keyword>CT Perfusion</keyword>
</DOC>